BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31554730)

  • 1. Outcomes of the short Synacthen test: what is the role of the 60 min sample in clinical practice?
    Dineen R; Mohamed A; Gunness A; Rakovac A; Cullen E; Barnwell N; Neary C; Behan LA; Boran G; Gibney J; Sherlock M
    Postgrad Med J; 2020 Feb; 96(1132):67-72. PubMed ID: 31554730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the utility of the 60 min cortisol measurement in the short synacthen test.
    Chitale A; Musonda P; McGregor AM; Dhatariya KK
    Clin Endocrinol (Oxf); 2013 Jul; 79(1):14-9. PubMed ID: 22747889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do we need 30 min cortisol measurement in the short synacthen test: a retrospective study.
    Kumar R; Carr P; Moore K; Rajput Z; Ward L; Wassif WS
    Postgrad Med J; 2020 Aug; 96(1138):467-472. PubMed ID: 31810992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sixty-minute post-Synacthen serum cortisol level: a reliable and cost-effective screening test for excluding adrenal insufficiency compared to the conventional short Synacthen test.
    Mansoor S; Islam N; Siddiqui I; Jabbar A
    Singapore Med J; 2007 Jun; 48(6):519-23. PubMed ID: 17538749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of morning serum cortisol as an alternative to short synacthen test for the assessment of adrenal reserve; a retrospective study.
    Kumar R; Carr P; Wassif W
    Postgrad Med J; 2022 Feb; 98(1156):113-118. PubMed ID: 33122342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How good is a morning cortisol in predicting an adequate response to intramuscular synacthen stimulation?
    Yo WS; Toh LM; Brown SJ; Howe WD; Henley DE; Lim EM
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):19-24. PubMed ID: 24274236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of sampling times and serum cortisol cut-off concentrations on the routine assessment of adrenal function using the standard cosyntropin test in an academic hospital from Spain: a retrospective chart review.
    Ortiz-Flores AE; Santacruz E; Jiménez-Mendiguchia L; García-Cano A; Nattero-Chávez L; Escobar-Morreale HF; Luque-Ramírez M
    BMJ Open; 2018 May; 8(5):e019273. PubMed ID: 29730618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the 1 μg short synacthen test: an assessment of morning cortisol cut-off values and other predictors.
    Perton FT; Mijnhout GS; Kollen BJ; Rondeel JM; Franken AA; Groeneveld PH
    Neth J Med; 2017 Jan; 75(1):14-20. PubMed ID: 28124663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "A morning cortisol is the most effective clinical predictor of short synacthen test outcome": A tertiary care centre experience.
    Mathara Diddhenipothage SAD; Beck KJ; Loo H; Amiyangoda GK; Pofi R; Tomlinson JW; Pal A
    Clin Endocrinol (Oxf); 2023 Aug; 99(2):142-151. PubMed ID: 37288515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tests of adrenal insufficiency.
    Agwu JC; Spoudeas H; Hindmarsh PC; Pringle PJ; Brook CG
    Arch Dis Child; 1999 Apr; 80(4):330-3. PubMed ID: 10086937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic studies of nasal tetracosactide with salivary glucocorticoids for a noninvasive Short Synacthen Test.
    Elder CJ; Vilela R; Johnson TN; Taylor RN; Kemp EH; Keevil BG; Cross AS; Ross RJ; Wright NP
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32593173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of adrenal function using the human corticotrophin-releasing hormone test, low dose Synacthen test and 9am cortisol level in children and adolescents with central adrenal insufficiency.
    Maguire AM; Biesheuvel CJ; Ambler GR; Moore B; McLean M; Cowell CT
    Clin Endocrinol (Oxf); 2008 May; 68(5):683-91. PubMed ID: 18070143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol.
    Woods CP; Argese N; Chapman M; Boot C; Webster R; Dabhi V; Grossman AB; Toogood AA; Arlt W; Stewart PM; Crowley RK; Tomlinson JW
    Eur J Endocrinol; 2015 Nov; 173(5):633-42. PubMed ID: 26294794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the utility of 30- and 60-minute cortisol levels after the standard short synacthen test to determine adrenal insufficiency: A retrospective cross-sectional study.
    Butt MI; Alzuhayri N; Amer L; Riazuddin M; Aljamei H; Khan MS; Abufarhaneh M; Alrajhi E; Alnassar A; Alahmed R; Aljayar DMA; Abothenain FF; De Vol E
    Medicine (Baltimore); 2020 Oct; 99(43):e22621. PubMed ID: 33120750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cut-off values for sufficient cortisol response to low dose Short Synacthen Test after surgery for non-functioning pituitary adenoma.
    Kolnes AJ; Øystese KA; Dahlberg D; Berg-Johnsen J; Niehusmann P; Pahnke J; Bollerslev J; Jørgensen AP
    Acta Neurochir (Wien); 2020 Apr; 162(4):845-852. PubMed ID: 31907611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can a random serum cortisol reduce the need for short synacthen tests in acute medical admissions?
    Kadiyala R; Kamath C; Baglioni P; Geen J; Okosieme OE
    Ann Clin Biochem; 2010 Jul; 47(Pt 4):378-80. PubMed ID: 20488874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is a 0900-h serum cortisol useful prior to a short synacthen test in outpatient assessment?
    Le Roux CW; Meeran K; Alaghband-Zadeh J
    Ann Clin Biochem; 2002 Mar; 39(Pt 2):148-50. PubMed ID: 11930947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The short Synacthen and insulin stress tests in the assessment of the hypothalamic-pituitary-adrenal axis.
    Hurel SJ; Thompson CJ; Watson MJ; Harris MM; Baylis PH; Kendall-Taylor P
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):141-6. PubMed ID: 8849566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease.
    Abdu TA; Elhadd TA; Neary R; Clayton RN
    J Clin Endocrinol Metab; 1999 Mar; 84(3):838-43. PubMed ID: 10084558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal cortisol response to high-dose synacthen and insulin tolerance test in children and adults with Prader-Willi syndrome.
    Farholt S; Sode-Carlsen R; Christiansen JS; Østergaard JR; Høybye C
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E173-80. PubMed ID: 20980432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.